Phase II study of sunitinib in patients with recurrent and/or metastatic squamous head and neck carcinoma: The GORTEC 2006-01 study

被引：0
|
作者：
Machiels, J. H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Henry, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Zanetta, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Kaminsky, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Michoux, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Bompas, E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Dillies, A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Faivre, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Schmitz, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Guigay, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Catholic Univ Louvain, B-1200 Brussels, Belgium
[2] Mont Godinne UCL Yvoir, Yvoir, Belgium
[3] Clin St Elizabeth, Namur, Belgium
[4] Ctr George Francois Leclerc, Dijon, France
[5] Ctr Alexis Vautrin, Nancy, France
[6] Ctr Rene Gauducheau, St Herblain, France
[7] Ctr Jean Perrin, Clermont Ferrand, France
[8] Hop Beaujon, AP HP, Paris, France
[9] Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6024
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
    Seiwert, T. Y.
    Fayette, J.
    Cupissol, D.
    del Campo, J. M.
    Clement, P. M.
    Hitt, R.
    Degardin, M.
    Zhang, W.
    Blackman, A.
    Ehrnrooth, E.
    Cohen, E. E. W.
    ANNALS OF ONCOLOGY, 2014, 25 (09) : 1813 - 1820
  • [42] Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study
    Stier, S
    Koll, C
    Neuhaus, T
    Fronhoffs, S
    Forkert, R
    Tuohimaa, A
    Vetter, H
    Ko, Y
    ANTI-CANCER DRUGS, 2005, 16 (10) : 1115 - 1121
  • [43] Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
    Kao, Hsiang-Fong
    Liao, Bin-Chi
    Huang, Yen-Lin
    Huang, Huai-Cheng
    Chen, Chun-Nan
    Chen, Tseng-Cheng
    Hong, Yuan-Jing
    Chan, Ching-Yi
    Chia, Jean-San
    Hong, Ruey-Long
    CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1560 - 1571
  • [44] Hyperfractionated reirradiation with cetuximab for recurrent head and neck cancer: The GORTEC 2008-01 multicentric phase II study.
    Saint-Ghislain, Mathilde
    Tao, Yungan
    Alfonsi, Marc
    Boisselier, Pierre
    Garcia-Ramirez, Muriel
    Tuchais, Claude
    Maingon, Philippe
    Sire, Christian
    Hasbini, Ali
    Saliou, Marie
    Lafond, Cedrik
    Qiu, Hao
    Guihard, Sebastien
    Garaud, Pascal
    Calais, Marie-Helene
    Thariat, Juliette
    Martin, Laurent
    Bourhis, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773
  • [46] Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck
    Gilbert, Jill
    Cmelak, Anthony
    Shyr, Yu
    Netterville, James
    Burkey, Brian B.
    Sinard, Robert J.
    Yarbrough, Wendall G.
    Chung, Christine H.
    Aulino, Joseph M.
    Murphy, Barbara A.
    CANCER, 2008, 113 (01) : 186 - 192
  • [47] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
  • [48] A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Dennis, Michael J.
    Sacco, Assuntina G.
    Qi, Yuchen
    Bykowski, Julie
    Pittman, Emily
    Chen, Ruifeng
    Messer, Karen
    Cohen, Ezra E. W.
    Gold, Kathryn A.
    ORAL ONCOLOGY, 2022, 135
  • [49] Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Seront, E.
    Schmitz, S.
    Rottey, S.
    Henry, S.
    Lonchay, C.
    van Caloen, G.
    Gilain, A.
    Machiels, J-P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Bourhis, Jean
    Rivera, Fernando
    Mesia, Ricard
    Awada, Ahmad
    Geoffrois, Lionel
    Borel, Christian
    Humblet, Yves
    Lopez-Pousa, Antonio
    Hitt, Ricardo
    Vega Villegas, M. Eugenia
    Duck, Lionel
    Rosine, Dominique
    Amellal, Nadia
    Schueler, Armin
    Harstrick, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2866 - 2872
12345